Product
Alpha-tocopheryloxyacetic Acid
Aliases
12-trimethyltridecyl) chroman-6-yloxy) Acetic Acid, 261929-52-6, alpha-TEA, a-TEA
1 clinical trial
3 indications
Indication
Breast Cancer, Stage IVIndication
HER2-Positive Breast CarcinomaIndication
Breast CancerClinical trial
A Phase I Dose Escalation Trial of Alpha-Tocopheryloxyacetic Acid (α-TEA) in Patients With Treatment Refractory HER2+ Metastatic Breast CancerStatus: Recruiting, Estimated PCD: 2024-02-01